SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies
Nat Med
.
2021 May;27(5):759-761.
doi: 10.1038/s41591-021-01347-0.
Authors
Emanuele Andreano
1
,
Rino Rappuoli
2
3
Affiliations
1
Monoclonal Antibody Discovery Lab, , Fondazione Toscana Life Sciences, Siena, Italy.
2
Monoclonal Antibody Discovery Lab, , Fondazione Toscana Life Sciences, Siena, Italy. rino.r.rappuoli@gsk.com.
3
Faculty of Medicine, Imperial College London, London, UK. rino.r.rappuoli@gsk.com.
PMID:
33972793
DOI:
10.1038/s41591-021-01347-0
No abstract available
MeSH terms
COVID-19 / prevention & control*
Humans
Immune Evasion*
Immunity, Innate / immunology*
SARS-CoV-2 / immunology*
Viral Vaccines / immunology*
Substances
Viral Vaccines